首页> 美国卫生研究院文献>BMC Musculoskeletal Disorders >Current therapeutic strategies of heterotopic ossification – a survey amongst orthopaedic and trauma departments in Germany
【2h】

Current therapeutic strategies of heterotopic ossification – a survey amongst orthopaedic and trauma departments in Germany

机译:当前异位骨化的治疗策略–德国骨科和创伤科室的一项调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundHeterotopic ossification (HO) is a complication after tissue trauma, fracture and surgery (i.e. total hip arthroplasty). Prophylaxis is the most effective therapy. If HO formations become symptomatic and limit patients’ quality of life, revision surgery is indicated and is usually combined with a perioperative oral prophylaxis (NSAIDs) and/or irradiation. However, a long-term use of NSAIDs can induce gastro-intestinal or cardiac side-effects and possible bony non-unions during fracture healing. Subject of this study was to assess the current status of HO prophylaxis after injuries or fractures and to evaluate current indications and strategies for excision of symptomatic HO.
机译:背景异位骨化(HO)是组织外伤,骨折和手术后的并发症(即全髋关节置换术)。预防是最有效的疗法。如果HO形成症状并限制患者的生活质量,则需要进行翻修手术,通常会与围手术期口服预防性治疗(NSAID)和/或放疗相结合。但是,长期使用NSAID可能会在骨折愈合期间引起胃肠道或心脏方面的副作用,并可能引起骨不愈合。本研究的主题是评估受伤或骨折后HO预防的现状,并评估对症性HO切除的当前适应症和策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号